Company
Hudson Biotech
Hudson Biotech has 5 drugs tracked on RxWires: 1 in Phase 3, 3 in Phase 2, 1 in Phase 1/2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Tirzepatide | Phase 3 | Obesity |
| Tesamorelin | Phase 2 | Metabolic Associated Steatotic Liver Disease |
| Melanotan II (MT-II) | Phase 2 | NonSegmental Vitiligo |
| Retatrutide (LY3437943) | Phase 2 | Obesity |
| TB-500 | Phase 1/2 | Atherosclerotic Cardiovascular Diseases |
Latest
No recent events.
Follow Hudson Biotech on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.